News from takeda A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 20, 2014, 08:00 ET

Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults

 Takeda Pharmaceutical Company Limited ("Takeda"), its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A., Inc. and Orexigen®...

Oct 03, 2014, 17:14 ET

Takeda Responds to Verdict in Diabetes Drug Case

 Takeda Pharmaceuticals U.S.A., Inc. today announced that in the case of Frances Wisniewski v. Takeda Pharmaceuticals North America, Inc., et...

Sep 11, 2014, 07:00 ET

Takeda and Orexigen Announce FDA Approval of Contrave® (naltrexone HCI and bupropion HCI) Extended-release Tablets for Chronic Weight Management

 Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. (Nasdaq: OREX) jointly announced today that the U.S. Food and Drug...

Sep 09, 2014, 11:50 ET
http://www.multivu.com/assets/7123051/photos/CONNECT2DAY-FACT-SHEET-md.jpg?1409704429

American Diabetes Association and Takeda Launch ConnecT2Day™ to Encourage Better Self-Management by Patients with Type 2 Diabetes

 Today, the American Diabetes Association (Association) and Takeda Pharmaceuticals, U.S.A., Inc. (Takeda) unveiled ConnecT2Day™, a...

Sep 03, 2014, 13:37 ET

Takeda Responds to Judgment in Diabetes Drug Case

 Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that...

Aug 28, 2014, 12:09 ET

Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS

Takeda Pharmaceutical Company Limited ("Takeda") today announced the completion of the post-marketing commitment and submissions of data from...

Jul 10, 2014, 09:00 ET

Takeda and Zinfandel Pharmaceuticals to Present Data at Upcoming Alzheimer's Association International Conference® Highlighting Innovative Approaches to Alzheimer's Disease Research and Development

 Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc. ("Zinfandel"), will present data during...

Jun 17, 2014, 09:00 ET

Results of a New Study of Brintellix® (vortioxetine) vs. Escitalopram on Sexual Functioning in Well Treated MDD Patients Experiencing Treatment-Emergent Sexual Dysfunction

Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual...

Jun 16, 2014, 10:00 ET

ENTYVIO™ (vedolizumab) Now Available in the United States for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis and Crohn's Disease

 Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced the...

Jun 16, 2014, 06:30 ET

New CONNECT Study Presents data on Measures of Cognitive Performance in Adult Patients Treated with Brintellix® (vortioxetine) for Major Depressive Disorder

 Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced results from CONNECT, a new study that evaluated...

May 22, 2014, 16:52 ET

Jury Finds for Takeda in Diabetes Drug Case

Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Bertha Triana and Delores Cipriano v. Takeda, et al., No. A680556 the...

May 20, 2014, 18:14 ET

FDA Approves Takeda's Entyvio™ (vedolizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the...

May 15, 2014, 16:52 ET

Jury Finds for Takeda in Diabetes Drug Case

 Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Whitlatch v. Takeda the jury found in favor of Takeda. The trial...

Apr 08, 2014, 00:51 ET

Takeda Responds to Verdict in Diabetes Drug Case

 Takeda Pharmaceuticals U.S.A., Inc. announced that in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al,...

Mar 27, 2014, 08:00 ET

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

Takeda Pharmaceutical Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes:...

Mar 18, 2014, 10:47 ET

Takeda nomme Giles Platford au poste de Directeur des marchés émergents

Takeda Pharmaceuticals International GmbH (« Takeda ») a annoncé aujourd'hui la nomination de Giles Platford au poste de Directeur...

Mar 18, 2014, 05:00 ET

Takeda nomeia Giles Platford para chefia de Mercados Emergentes

A Takeda Pharmaceuticals International GmbH ("Takeda") anunciou hoje que Giles Platford foi nomeado chefe de Operações Comerciais de...

Mar 18, 2014, 05:00 ET

Takeda nombra director de mercados emergentes a Giles Platford

Takeda Pharmaceuticals International GmbH ("Takeda") anunció hoy que Giles Platford asumió la dirección de operaciones...

Mar 18, 2014, 05:00 ET

Takeda Appoints Giles Platford Head of Emerging Markets

Takeda Pharmaceuticals International GmbH ("Takeda") today announced that Giles Platford has been appointed Head of Commercial Operations,...

Jan 21, 2014, 09:00 ET

Takeda and Lundbeck Announce Brintellix® (vortioxetine) for the Treatment of Major Depressive Disorder in Adults is Now Available in Pharmacies

Takeda Pharmaceuticals U.S.A., Inc. (Takeda) and Lundbeck US jointly announced today that Brintellix (vortioxetine), for the treatment of major...